Sign In

Login

Password

Forgot Password ? Sign Up

18-Methoxycoronaridine (French Wikipedia)

Analysis of information sources in references of the Wikipedia article "18-Methoxycoronaridine" in French language version.

refsWebsite
Global rank French rank
10nih.gov
4th place
12th place
10doi.org
2nd place
3rd place
1harvard.edu
18th place
118th place
1timesunion.com
2,970th place
low place
1clinicaltrials.gov
5,225th place
6,624th place

clinicaltrials.gov

doi.org

dx.doi.org

  • « 18-Methoxycoronaridine, a non-toxic iboga alkaloid congener: effects on morphine and cocaine self-administration and on mesolimbic dopamine release in rats », Brain Research, vol. 719, nos 1–2,‎ , p. 29–35 (PMID 8782860, DOI 10.1016/0006-8993(96)00056-X)
  • « Brain regions mediating alpha3beta4 nicotinic antagonist effects of 18-MC on methamphetamine and sucrose self-administration », European Journal of Pharmacology, vol. 599, nos 1–3,‎ , p. 91–5 (PMID 18930043, PMCID 2600595, DOI 10.1016/j.ejphar.2008.09.038)
  • « Anti-addictive actions of an iboga alkaloid congener: a novel mechanism for a novel treatment », Pharmacology, Biochemistry, and Behavior, vol. 75, no 3,‎ , p. 607–18 (PMID 12895678, DOI 10.1016/S0091-3057(03)00119-9)
  • « Effect of Iboga alkaloids on µ-opioid receptor-coupled G protein activation », PLOS ONE, vol. 8, no 10,‎ , e77262 (PMID 24204784, PMCID 3818563, DOI 10.1371/journal.pone.0077262, Bibcode 2013PLoSO...877262A)
  • « 18-Methoxycoronaridine acts in the medial habenula and/or interpeduncular nucleus to decrease morphine self-administration in rats », European Journal of Pharmacology, vol. 537, nos 1–3,‎ , p. 94–8 (PMID 16626688, DOI 10.1016/j.ejphar.2006.03.045)
  • « 18-MC acts in the medial habenula and interpeduncular nucleus to attenuate dopamine sensitization to morphine in the nucleus accumbens », Synapse, vol. 61, no 7,‎ , p. 547–60 (PMID 17447255, DOI 10.1002/syn.20396)
  • « Morphine-induced changes in acetylcholine release in the interpeduncular nucleus and relationship to changes in motor behavior in rats », Neuropharmacology, vol. 53, no 1,‎ , p. 18–26 (PMID 17544456, PMCID 2025684, DOI 10.1016/j.neuropharm.2007.04.010)
  • « 18-methoxycoronaridine: a potential new treatment for obesity in rats? », Psychopharmacology, vol. 201, no 3,‎ , p. 339–50 (PMID 18751969, PMCID 3787601, DOI 10.1007/s00213-008-1290-9)
  • « Synthesis and biological evaluation of 18-methoxycoronaridine congeners. Potential antiaddiction agents », Journal of Medicinal Chemistry, vol. 46, no 13,‎ , p. 2716–30 (PMID 12801235, DOI 10.1021/jm020562o)
  • « Novel iboga alkaloid congeners block nicotinic receptors and reduce drug self-administration », European Journal of Pharmacology, vol. 492, nos 2–3,‎ , p. 159–67 (PMID 15178360, DOI 10.1016/j.ejphar.2004.03.062)

harvard.edu

ui.adsabs.harvard.edu

nih.gov

ncbi.nlm.nih.gov

  • « 18-Methoxycoronaridine, a non-toxic iboga alkaloid congener: effects on morphine and cocaine self-administration and on mesolimbic dopamine release in rats », Brain Research, vol. 719, nos 1–2,‎ , p. 29–35 (PMID 8782860, DOI 10.1016/0006-8993(96)00056-X)
  • « Brain regions mediating alpha3beta4 nicotinic antagonist effects of 18-MC on methamphetamine and sucrose self-administration », European Journal of Pharmacology, vol. 599, nos 1–3,‎ , p. 91–5 (PMID 18930043, PMCID 2600595, DOI 10.1016/j.ejphar.2008.09.038)
  • « Anti-addictive actions of an iboga alkaloid congener: a novel mechanism for a novel treatment », Pharmacology, Biochemistry, and Behavior, vol. 75, no 3,‎ , p. 607–18 (PMID 12895678, DOI 10.1016/S0091-3057(03)00119-9)
  • « Effect of Iboga alkaloids on µ-opioid receptor-coupled G protein activation », PLOS ONE, vol. 8, no 10,‎ , e77262 (PMID 24204784, PMCID 3818563, DOI 10.1371/journal.pone.0077262, Bibcode 2013PLoSO...877262A)
  • « 18-Methoxycoronaridine acts in the medial habenula and/or interpeduncular nucleus to decrease morphine self-administration in rats », European Journal of Pharmacology, vol. 537, nos 1–3,‎ , p. 94–8 (PMID 16626688, DOI 10.1016/j.ejphar.2006.03.045)
  • « 18-MC acts in the medial habenula and interpeduncular nucleus to attenuate dopamine sensitization to morphine in the nucleus accumbens », Synapse, vol. 61, no 7,‎ , p. 547–60 (PMID 17447255, DOI 10.1002/syn.20396)
  • « Morphine-induced changes in acetylcholine release in the interpeduncular nucleus and relationship to changes in motor behavior in rats », Neuropharmacology, vol. 53, no 1,‎ , p. 18–26 (PMID 17544456, PMCID 2025684, DOI 10.1016/j.neuropharm.2007.04.010)
  • « 18-methoxycoronaridine: a potential new treatment for obesity in rats? », Psychopharmacology, vol. 201, no 3,‎ , p. 339–50 (PMID 18751969, PMCID 3787601, DOI 10.1007/s00213-008-1290-9)
  • « Synthesis and biological evaluation of 18-methoxycoronaridine congeners. Potential antiaddiction agents », Journal of Medicinal Chemistry, vol. 46, no 13,‎ , p. 2716–30 (PMID 12801235, DOI 10.1021/jm020562o)
  • « Novel iboga alkaloid congeners block nicotinic receptors and reduce drug self-administration », European Journal of Pharmacology, vol. 492, nos 2–3,‎ , p. 159–67 (PMID 15178360, DOI 10.1016/j.ejphar.2004.03.062)

timesunion.com